G Liberale1, S Vankerckhove2, M G Galdon3, V Donckier4, D Larsimont5, P Bourgeois6. 1. Department of Surgical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium. Electronic address: gabriel.liberale@bordet.be. 2. Department of Nuclear Medicine and Clinic-Unit of Lymphology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium. Electronic address: Sophie_VANKERCKHOVE@stpierre-bru.be. 3. Department of Anatomo-Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium. Electronic address: maria.gomezgaldon@bordet.be. 4. Department of Surgical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium. Electronic address: Vincent.donckier@bordet.be. 5. Department of Anatomo-Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium. Electronic address: denis.larsimont@bordet.be. 6. Department of Nuclear Medicine and Clinic-Unit of Lymphology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium. Electronic address: pierre.bourgeois@bordet.be.
Abstract
PURPOSE: This short communication aims at reporting the potential role of ICG fluorescence imaging after an intraoperative IV injection in the detection of lymph nodes (LNs) of a colorectal cancer origin. PATIENTS AND METHODS: Two patients who were included in a protocol study evaluating the role of ICG in the detection of peritoneal metastases of colorectal origin (Protocol NCT-01995591) also had fluorescent LNs at exploration with a dedicated near-infrared camera system (Photodynamic Eye, PDE; Hamamatsu Photonics, Hamamatsu, Japan). An IV injection of ICG was delivered intraoperatively at 0.25 mg/kg. All LNs were also explored for their fluorescence, and tumor to background ratio (TBR) was calculated with IC-Calc 2.0 program. RESULTS: One patient had two retroperitoneal lymph node metastases and one mesocolic on a pre-operative work-up. The three tumoural lymph nodes at histopathology were hyperfluorescent in comparison to other uninvolved LNs. One patient had no pre-operatively known LN metastases and had one epigastric hyperfluorescent LN discovered at intraoperative exploration. This LN of 6 mm in size was malignant at histopathology. CONCLUSION: This is the first report about tumoural LN of colorectal cancer origin detected by fluorescence imaging with intraoperative IV free-ICG injection. ICG fluorescence imaging by intraoperative IV injection represents an easy method for detecting metastatic LNs in colorectal cancer. This proof of concept should lead to further research in this field.
PURPOSE: This short communication aims at reporting the potential role of ICG fluorescence imaging after an intraoperative IV injection in the detection of lymph nodes (LNs) of a colorectal cancer origin. PATIENTS AND METHODS: Two patients who were included in a protocol study evaluating the role of ICG in the detection of peritoneal metastases of colorectal origin (Protocol NCT-01995591) also had fluorescent LNs at exploration with a dedicated near-infrared camera system (Photodynamic Eye, PDE; Hamamatsu Photonics, Hamamatsu, Japan). An IV injection of ICG was delivered intraoperatively at 0.25 mg/kg. All LNs were also explored for their fluorescence, and tumor to background ratio (TBR) was calculated with IC-Calc 2.0 program. RESULTS: One patient had two retroperitoneal lymph node metastases and one mesocolic on a pre-operative work-up. The three tumoural lymph nodes at histopathology were hyperfluorescent in comparison to other uninvolved LNs. One patient had no pre-operatively known LN metastases and had one epigastric hyperfluorescent LN discovered at intraoperative exploration. This LN of 6 mm in size was malignant at histopathology. CONCLUSION: This is the first report about tumoural LN of colorectal cancer origin detected by fluorescence imaging with intraoperative IV free-ICG injection. ICG fluorescence imaging by intraoperative IV injection represents an easy method for detecting metastatic LNs in colorectal cancer. This proof of concept should lead to further research in this field.
Authors: E Villegas-Tovar; J Jimenez-Lillo; V Jimenez-Valerio; A Diaz-Giron-Gidi; R Faes-Petersen; A Otero-Piñeiro; F B De Lacy; R J Martinez-Portilla; A M Lacy Journal: Surg Endosc Date: 2019-11-21 Impact factor: 4.584
Authors: Gabriel Liberale; Sophie Vankerckhove; Fikri Bouazza; Maria Gomez Galdon; Denis Larsimont; Michel Moreau; Pierre Bourgeois; Vincent Donckier Journal: JMIR Res Protoc Date: 2020-08-14
Authors: Pierre Bourgeois; Isabelle Veys; Danielle Noterman; Filip De Neubourg; Marie Chintinne; Sophie Vankerckhove; Jean-Marie Nogaret Journal: Front Oncol Date: 2021-03-09 Impact factor: 6.244